Atlas Trials

Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma

Clinical trial NCT04673266 · COMPLETED

Trial details

NCT number
NCT04673266
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma PatientsThrombocytopenia
Start date
2020-12-14
Primary completion
2026-04-07
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.